NICM HRI Webinar 2022: Trial Breakthrough for Patients with Glioblastoma
|Event Name||NICM HRI Webinar 2022: Trial Breakthrough for Patients with Glioblastoma|
|Start Date||13th Dec 2022 10:00 am|
|End Date||13th Dec 2022 11:00 am|
NICM Health Research Institute (NICM HRI) presents Dr Janet Schloss, Clinical Research Fellow and Lecturer at Southern Cross University's National Centre for Naturopathic Medicine and Adjunct Fellow at NICM HRI.
Join guest webinar speaker Dr Janet Schloss as she discusses a randomised clinical trial investigating cannabis tolerability by patients with brain tumours.
Dr Janet Schloss is an accomplished researcher with extensive experience in coordinating clinical trials. In addition to her academic career, Dr Schloss is also a practicing clinical nutritionist and naturopath with over 20 years’ experience. Following the completion of her doctorate in 2015, she has focused her research on supporting people who have cancer through studying the use of complementary medicines to assist side effects of chemotherapy and radiation treatments. In addition, Dr Schloss has now worked extensively conducting trials with medicinal cannabis.
A randomised clinical trial was conducted on patients with glioblastoma or astrocytoma grade three recurrent, the most aggressive brain tumours in adults. The trial investigated the tolerability of two ratios of cannabis administered to patients for 12-weeks. An MRI was conducted at baseline and 12-weeks with bloods taken at baseline, week 4, 8 and 12. Safety data as well as pharmacokinetics were conducted on these blood samples. Patients were also followed up for two years post trial for survival and continuation of taking cannabis in this period. The results of the trial, PK and follow up will presented.
Keywords: GBM, cannabis, brain cancer, survival rate, high grade gliomas
How to join and requirements:
Our online seminars use the Zoom platform. Joining the webinar is easy. If you don’t already use Zoom don’t worry, Zoom will download automatically when you click the link to join the webinar. This link will be provided to you in a confirmation email upon registration, and is the easiest and more direct way to join the webinar. Alternatively you can go to the Zoom website https://zoom.us/join (opens in a new window) and enter the Meeting ID (provided in the confirmation email) and click join. Otherwise, you can also dial in on the phone number (provided in the confirmation email). A reminder email will also be sent an hour prior to the webinar commencing. If you have any questions before the day, please contact our seminar programs team at email@example.com
To ensure a seamless learning experience, please follow these simple steps:
Please note this webinar will not require a webcam or audio for participants. This webinar will have the Q&A function available for questions at the end of the webinar and a recording may also be made available to participants. Closed captioning is available for this webinar, however please note the live transcript is automatically generated and accuracy may be limited due to this.
Webinar recording disclaimer:
WHEN: Tuesday 13 December 2022
VENUE: Zoom webinar